Research programme: anti-B-cell receptor monoclonal antibodies - Genitope

Drug Profile

Research programme: anti-B-cell receptor monoclonal antibodies - Genitope

Alternative Names: Anti-BCR monoclonal antibodies; Non-Hodgkin's lymphoma therapeutics - Genitope

Latest Information Update: 24 Dec 2013

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Genitope Corporation
  • Class Monoclonal antibodies
  • Mechanism of Action B cell inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Non-Hodgkin's lymphoma

Most Recent Events

  • 11 Dec 2007 Preclinical pharmacodynamics data presented at the 49th Annual Meeting and Exposition of the American Society of Hematology (ASH-2007)
  • 05 Apr 2006 Preclinical trials in Non-Hodgkin's lymphoma in USA (IV-injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top